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Purpose: Determine the feasibility of 1H-[13C] MRS in the mouse hypothalamus
using a 14.1T magnet.
Methods: We optimized the design of a 1H-[13C] surface coil to maximize the signal-
to-noise ratio of 1H-[13C] MRS in the mouse hypothalamus. With enhanced signal,
13C accumulation in glucose metabolites was measured in a 8.7mL voxel in the hypo-
thalamus of 5 healthy mice during the continuous administration of [1,6-13C2]glucose.
Results: Accumulation of 13C label in glucose C6 and lactate C3 was visible in the
hypothalamus 11min after glucose administration. The 13C fractional enrichment
(FE) curves of lactate C3, glutamate and glutamine C4, glutamate1glutamine C3 and
C2, GABA C2, C3, and C4, and aspartate C3 were measured with a time resolution
of 11min over 190min. FE time-courses and metabolic pool sizes were averaged to
fit a novel one-compartment model of brain energy metabolism that incorporates the
main features of the hypothalamus.
Conclusion: Dynamic 1H-[13C] MRS is able to measure in vivo brain metabolism in
small and deep areas of the mouse brain such as the hypothalamus, and it can be used
to calculate metabolic fluxes, including glutamatergic and GABAergic metabolism as
well as the contribution of metabolic sources other than glucose.
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1 | INTRODUCTION
13C MRS is a particularly versatile technique for noninva-
sively investigating brain metabolism. When used in combi-
nation with labeled substrates and high field magnets, the
increased sensitivity of the technique can be used to explore
small areas of the human and rat brain.1,2 13C MRS experi-
ments are typically performed while infusing [1-13C]glucose,
[1,6-13C2]glucose, or [2-
13C]acetate solutions into the blood
and following their metabolism. During metabolic turnover,
13C label is incorporated into various metabolites, and the
more abundant ones are detectable by MRS. The label redis-
tribution can be detected dynamically in vivo by 13C MRS,
and the application of appropriate mathematical models
allows the calculation of metabolic fluxes.3
Compared with 1H MRS, one of the major drawbacks of
13C MRS is its lower sensitivity, which generally restricts its
use to relatively large voxels placed close to a surface coil.
Recent technological advances, however, such as increased
magnetic field, improved shimming techniques, localization
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methods, and RF coil designs have led to substantially
greater sensitivity in direct and indirect 13C MRS measure-
ments.4 For example, the surface coil arrangement designed
by Adriany and Gruetter,5 in which two 1H loops were
placed in quadrature and combined with a linearly polarized
13C surface coil in between, enhanced detection sensitivity
and enabled measurements in reduced volumes. With these
improvements, both the rat and the mouse brain have been
investigated using direct 13C MRS.6–8
The hypothalamus is a small area deep inside the brain
that senses energy metabolites, such as glucose, fatty acids,
and ketone bodies, and hormones, such as leptin.9–12 It con-
tains different neuronal populations that participate in the
short- and long-term regulation of energy balance,13 and the
neurotransmitters glutamate and g-aminobutyrate (GABA)
are present in most of its neurons.14 The hypothalamus is a
key regulator of glucose metabolism and insulin secretion,15
and hypothalamic inflammation is implicated in the onset
and development of obesity.16 The establishment of a nonin-
vasive approach to monitor hypothalamic metabolism could
provide valuable new insights into the understanding of its
normal function and in the longitudinal detection of any local
changes during the course of a disease.
Earlier studies have used 1H and 13C MRS to investigate
the hypothalamus, both in rodents and in humans,17–21 and
despite its small size and remote location in the brain, its neu-
rochemical profile can be characterized in vivo.22 13C MRS
in vivo in the mouse hypothalamus has not been reported
thus far, and the direct detection of 13C label in such a small
area distant from the RF coil would require the use of high
magnetic field and maximized RF detection sensitivity to
deliver sufficient signal. In this sense, indirect 1H-[13C] MRS
detection methods, in which the 13C label is quantified by
evaluating the 13C-induced heteronuclear coupling modifica-
tions on the 1H resonances, can provide increased sensitivity,
although at the expense of a lower spectral resolution.23
The aim of our study, therefore, was to detect 13C turn-
over in the mouse hypothalamus in vivo by combining the
use of high magnetic field with indirect 1H-[13C] MRS detec-
tion and a homemade surface coil optimized for this experi-
ment. Furthermore, we calculated the local metabolic fluxes
of the mouse hypothalamus by adapting the existing models
of brain metabolism to include the metabolic activity of
GABAergic neurons and any input from fatty acids and
ketone bodies.24,25
2 | METHODS
2.1 | MR magnet and gradient coil
All measurements were carried out in a 14.1T magnet with a
26-cm-diameter horizontal bore (Magnex Scientific, Abing-
don, UK), equipped with a 12-cm internal diameter gradient
coil insert (400 mT/m, 120ls), and interfaced to a Direct-
Drive console (Varian, Palo Alto, CA).
2.2 | RF coils
We used two different homemade transmit/receive surface
coils: (1) the original 13C-[1H] surface coil used in Xin et al.6
with two 1H loops in quadrature (13mm, 600 MHz) com-
bined with a 13C linearly polarized loop (11mm, 150 MHz)
placed in between them, and (2) an optimized 1H-[13C] coil
with the 1H (11mm) loops placed below the 13C loop
(10mm) (Figure 1). The optimized 1H-[13C] surface coil
was designed specifically to enhance 1H sensitivity in the
hypothalamus by minimizing the distance between the 1H
loops and the mouse brain. Loop sizes were slightly modi-
fied to reach a reasonable compromise between geometrical
decoupling (i.e., -15 dB mutual coupling) and detection
sensitivity, with the final coil arrangement yielding a geo-
metrical coupling between the two 1H loops of -20 dB, and
1H-13C coupling between the 13C loop and each of the two
1H loops of -16 dB and -24 dB, respectively. A glass sphere
containing 13C labeled formic acid (FA) was set at the center
of the coils as a reference for 13C frequency offset and 13C
channel power calibration.26 In addition, to minimize cross-
talk between the 1H and 13C transmission and reception
lines during MRS experiments, proton- and carbon-
bandpass filters were placed between the coil loops and the
pre-amplifier.
2.3 | MR sequences
MR images were acquired with a fast spin echo (FSE)
sequence and the following parameters: TE5 54ms, repeti-
tion time5 4000ms, echo train length5 8, averages5 4, slice
thickness5 0.6mm, slices5 15, field of view5 203
20mm2, data matrix5 2563 256. The volumes of interest
(VOIs) in vivo, were positioned based upon referencing the
anatomical MR images to a mouse brain atlas.27 For the in
vitro acetate phantom tests, the VOIs were positioned with the
same distance from the coil as in the in vivo experiments
(5.1mm below brain surface).
Field homogeneity was optimized by adjusting both first
and second order shim gradients using FAST(EST)MAP
methods.28
1H-[13C] MRS data were acquired with a full-intensity
BISEP-SPECIAL sequence (BISEP: B1-insensitive spectral
editing pulse29; SPECIAL: SPin ECho, full Intensity
Acquired Localized spectroscopy30, with TE/TR5 2.8/
4000ms, 16 scans per block, and the 13C inversion pulse
alternating between OFF and ON in an interleaved mode.29
Optimization was performed for both the excitation and
refocusing pulses in the SE localization sequence.30 The
durations and bandwidths were 2 ms/10 kHz for the spatially
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selective adiabatic inversion pulse, 0.5 ms/13.7 kHz for the
excitation and 1 ms/6.7 kHz for refocusing. The resulting
maximum chemical shift displacement errors were less than
8%, 6%, and 12%, respectively.
Localization of the VOI was improved with outer volume
suppression.31 For satisfactory water suppression, seven
chemical shift-selective (CHESS) 15 ms RF pulses with vari-
able power and optimized relaxation delays (VAPOR) were
used, along with an additional 12-m Gaussian CHESS pulse
between the spatially-selective inversion pulse and the exci-
tation pulse.
In the BISEP module, the bandwidth of the inversion
pulse of 1H channel was 2 kHz (3.3 ppm at 14.1T) with
gB1max5 6.7 kHz, and the bandwidth of the inversion pulse
of 13C channel was 12 kHz (80 ppm at 14.1T) with
gB2max5 7 kHz.
Adiabatic 13C decoupling (hyperbolic secant HS8 adia-
batic full-passage pulse32 together with a MLEV-4 cycle and
five-step phase supercycle33 was applied during the entire
acquisition period (145 ms).
2.4 | Phantom setup
The quality of the 1H-[13C] MR hypothalamic signal was ini-
tially assessed on a phantom containing 50% enriched sodium
[2-13C]acetate (50mM, Sigma-Aldrich, St. Louis, MO). First,
SNRs of 1H-[13C] MR signals from two volumes: (1) a voxel
mimicking the mouse hypothalamus size (1.8mm3
2.7mm3 1.8mm) and depth (5.1mm below brain surface)
and (2) a voxel containing the mouse thalamus and cortex,
analogous to that in Xin et al.6 (5mm3 4mm3 3mm), were
compared using the original 13C-[1H] surface coil (Figure 1A).
The SNR of 1H-[13C]MR signal from the identical voxel mim-
icking the mouse hypothalamus using the optimized 1H-[13C]
surface coil was then determined (Figure 1B).
SNRs of six inverted and six non-inverted spectra (two
averages each) were evaluated manually by dividing the
maximum signal resonance intensity by the standard devia-
tion of the baseline. The corresponding SNRs of the different
voxels and coils were, respectively, averaged and compared
(Figure 1).
FIGURE 1 A, Schematic representation of the 13C-[1H] surface coil arrangement and the nondecoupledMRS spectra from the 50% labeled [2-13C]
acetate phantom. The two proton loops in quadrature (13mm) were placed on top of the 13C loop (11mm). The big (5mm3 4mm3 3mm) (top) and
small hypothalamic (1.8mm3 2.7mm3 1.8mm) (bottom) voxels were placed at 2.6mm and 5.1mm from the surface, respectively. The summed
inverted and non-inverted spectra (12 averages each, line broadening5 20Hz), from the top or bottom voxels, respectively, are plotted connected with the
two respective volumes by dotted lines. The vertical scale of the big voxel spectra was modified (3 0.5) to smooth visualization. B, Schematic representa-
tion of the optimized 1H-[13C] surface coil and resultingMRS spectra from the 50% labeled [2-13C]acetate phantom. The two proton loops in quadrature
(11mm) were located below the 13C loop (10mm) tomaximize 1H sensitivity of the mouse hypothalamus. The hypothalamic voxel
(1.8mm3 2.7mm3 1.8mm) was positioned at 5.1mm from the phantom surface. The summed inverted and non-inverted spectra (12 averages each, line
broadening5 20Hz) are shown connected to the hypothalamic voxel
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In addition, RF powers for inversion and decoupling in
the 13C channel were calibrated for the different voxel distan-
ces to the coil (measured on the MRI using the FA bubble as
landmark). The frequency offsets of the inversion pulses
were centered at 1.81 ppm for the 1H channel and 24.5 ppm
for the 13C channel, respectively. The 13C decoupling mod-
ule was centered at 24.5 ppm.
2.5 | Animal preparation
All experimental procedures involving animals were
approved by the local ethics committee (EXPANIM-SCAV,
Switzerland). Five adult (13 weeks old) male C57BL/6 mice
were fasted overnight (12 h) before experiments. Body
weight (296 1 g) and fasting blood glucose levels (5.16
1.3mM) were measured at each experimental session. Iso-
flurane anesthesia (3-4% for induction, 2% for cannulation,
1-1.5% for maintenance, mixed with 1:1 air:O2) was admin-
istrated through a nose cone and regulated to maintain a
breathing rhythm between 70 and 100 breaths per min (SA
Instruments, Stoney Brook, NY). Before the MR measure-
ments, a femoral vein was cannulated for the infusion of a
20% mass per volume solution of [1,6-13C2]glucose (Sigma-
Aldrich, St. Louis, MO). Then, animals were immobilized in
a semi-cylindrical home-built holder with a bite bar and the
head fixed with ear bars. Throughout the entire study, body
temperature was monitored with a rectal probe (SA Instru-
ments, Stoney Brook, NY) and maintained between 36.5 and
37.5 8C with a circulating water tube.
2.6 | 1H-[13C] MRS of the mouse
hypothalamus
In the hypothalamus voxel, field homogeneity was optimized
to a water linewidth of 166 2Hz. 13C power values were
chosen based on the measured voxel-to-coil distance and
adjusted for coil loading (as compared to the phantom tests),
using the FA flip angle optimization as a reference. The pro-
ton frequency offset of the inversion pulse was set to the res-
onance frequency of Glu C4 protons (2.34 ppm). The carbon
frequency offset of the inversion pulse was set to 40 ppm to
guarantee the complete inversion range between Glc C6
(62 ppm) and Lac C3 (21 ppm). The carrier frequency of the
13C decoupling pulse was centered at 40 ppm.
After optimizing the 1H-[13C] sequence parameters for
the dynamic 1H-[13C] MRS study of the mouse hypothala-
mus in vivo, the glucose solution was administered first as a
5-min bolus (4.01mL/kg of 99% enriched 13C glucose), fol-
lowed by a constant infusion (10mL/kg/h of 70% enriched
13C glucose) for the rest of the experiment. The infusion rate
was optimized to achieve a stable isotopic enrichment of
plasma glucose.34
2.7 | Data analysis
For each animal, five consecutive 13C-inverted and non-
inverted spectra, acquired in an interleaved mode, were fre-
quency corrected and added together, resulting in two 80-
scan blocks of inverted and non-inverted spectra. Each pair
of 80 inverted and non-inverted spectra was subtracted to
generate a 13C-edited difference spectrum (160 scans) with
an 11-min temporal resolution. Metabolite pool sizes were
calculated from the non-inverted spectra using LCModel35
and a standard basis set of metabolite spectra.36,37 This basis
set consists of simulations of 22 metabolites, including the
macromolecules, alanine (Ala), aspartate (Asp), phosphoryl-
choline (PCho), creatine (Cr), phosphocreatine (PCr),
GABA, glucose (Glc), glutamine (Gln), glutamate (Glu), glu-
tathione, glycine, myo-inositol (Ins), lactate (Lac), N-
acetylaspartate, scyllo-inositol, taurine, ascorbate, N-acetylas-
partylglutamate, glycerylphosphorylcholine (GPC), phos-
phoethanolamine, and acetate, which can be used to define a
neurochemical profile.
The intensities of the sum of Glu and Gln (Glx), the sum
of GPC1PCho, and total Cr (Cr1PCr) were provided by
LCModel. Cr1PCr values were used as an internal refer-
ence, assuming a total concentration of 8lmol/g.22,38 Quanti-
fication of the 13C-edited spectra was done using another
simulated basis set6 that contains the resonances of 1H
coupled to NAA C6, Glu (C2, C3, and C4), Gln (C2, C3,
and C4), GABA (C2, C3, and C4), Asp (C2 and C3), Glc
(C1 and C6), Glx (C2 and C3), Lac C3, and Ala C3. Correla-
tion values between the respective spectral intensities
obtained with LCModel were controlled for every time point
and animal. For some animals, GABA C3 and GABA C4
could not be detected in the first two time points, and its con-
tribution was not taken into account. SNRs values of the
both edited and non-edited spectra were obtained from
LCModel.
Isotopic fractional enrichment (FE) values were calcu-
lated from the ratios between the edited and non-edited spec-
tra, as described previously.29 For example, FE values for
Lac C3 were calculated at every time point by dividing the
Lac C3 concentration obtained from the 13C-edited spectra
by total Lac values derived from the non-edited spectra anal-
ysis. 13C concentrations were obtained by multiplying each
FE by the corresponding metabolite pool size.
Glx C2 and Glc C6 FEs and 13C concentrations were cor-
rected to account for their respective correlated quantifica-
tions. These high correlations derive from their overlapping
resonances in the 1H spectrum, which occur between 3.88
and 3.71 ppm (Glc C6) and 3.76 and 3.75 ppm (Glx C2), and
result in highly correlated signal intensities after LCModel-
fitting. Adjustments were performed assuming three condi-
tions: (1) no significant Glx C2 was labeled between t5 0
and t5 11min, suggesting that (2) the measurement of Glc
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C6 between t5 0 and t5 11min was accurate, and (3) FE of
Glc C6 was constant for the rest of the time course of the
experiment (FEGlc C6(t)5FEGlc C6(t56min)). Then, Glx C2 FEs
were calculated using the expression:
FEGlx C2(t)5(
13CGlc C6(t) LCModel1
13CGlx C2(t) LCModel-
1
HGlc t) LCModel*FEGlc C6(t56min))/
1HGlx(t) LCModel
where 13CGlc C6(t) LCModel and
13CGlx C2(t) LCModel represent
the respective 13C concentrations of Glc C6 and Glx C2
measured from the edited spectra, and 1HGlx(t)LCModel repre-
sents the total concentration of Glx measured from the non-
edited spectra.13C concentrations were corrected accordingly.
Total pool sizes, FEs and 13C concentrations were esti-
mated for every time point. Curves of all animals were aver-
aged and used for the metabolic flux analyses. Results are
shown as mean6 SD values except otherwise stated.
2.8 | Modeling of hypothalamic metabolism
Hypothalamic metabolism was evaluated using a novel one-
compartment model of brain metabolism (Figure 2) that
retains the most relevant metabolic features of astrocytes,
glutamatergic and GABAergic neurons by adapting a more
complex three-compartment approach39 to a single-TCA-
cycle model. Additionally, it includes the net contribution of
fatty acids and ketone bodies as non-labeled energy sub-
strates to hypothalamic metabolism.40–42 The metabolic
model was applied to fit average FE turnover curves of Glu
C4, Gln C4, GABA C2, GABA C3, GABA C4, Glx C3, Glx
C2, and Asp C3 and using average metabolic pool sizes.
Time resolution was set to 11min, except for Asp C3, where
it was increased to 18min to reach similar SNR. The Lac C3
curve, measured in the hypothalamus in vivo, was used as
the input function.6
Fitting was performed in MATLAB (Version 8.2, The
MathWorks, Inc., Natick, MA). Values of the metabolic rates
of the pyruvate dehydrogenase complex (VPDH), the tricar-
boxylic acid cycle (VTCA), the dilution flux (Vdil), the pyru-
vate carboxylase (VPC), the glutamate-GABA cycle
(VGABA), the glutamate-glutamine cycle (VGln), the transmi-
tochondrial flux (Vx), the efflux flux (Veff), and their respec-
tive uncertainties were calculated by a two-step method.
First, the fluxes were estimated using the FE curves weighted
by the inverse of their variance (based on their respective
noise level), with a standard built-in ordinary differential
equation solver and a modified Levenberg-Marquardt nonlin-
ear weighted regression method.6 Subsequently, precision of
the metabolic rates was determined by 300 Monte Carlo sim-
ulations of the FE time courses. The SD provided by their
respective fittings was used to define the rates’ uncertainties.3
Correlation values between fluxes were calculated during the
nonlinear regression algorithm. The resulting simulated FE
turnover curves of all measured 13C resonances, obtained
with values from the best fit of the metabolic fluxes, were
compared with the corresponding experimental curves to
evaluate the accuracy of the modeling. All corresponding
FIGURE 2 Schematic layout of the one-compartment model of hypothalamicmetabolism. Labeled and nonlabeled glucose (Glc) enters the brain and
is transformed into pyruvate (Pyr), which is in rapid exchange with lactate (Lac). Pyr is converted to acetyl-CoA (AcCoA) at a rate described by the pyru-
vate dehydrogenase flux (VPDH). Through an anaplerotic reaction, pyruvate carboxylase catalyzes the carboxylation of Pyr to form oxaloacetate (OAA) at
rateVPC. Ketone bodies and fatty acids (FA/KB) can also enter the brain, and by an oxidative removal of successive two-carbon units in the form of acetyl-
CoA, dilute AcCoA enrichment at rateVdil. AcCoA is further transformed to 2-oxoglutarate (OG) in the first turn of the TCA cycle, with a total consump-
tion rate ofVPDH1Vdil, equal to the sum of the oxidation fluxesVPC1VTCA1VGABA.VTCA represents the rate of conversion fromOG to OAA and
VGABA accounts for the GABA synthesis rate fromGlu and for its further oxidation in the TCA cycle, originating OAA. OG exchanges labeling symmetri-
cally with glutamate (Glu) bymeans of the transmitochondrial fluxVx, whileVPC andVGABA support a net conversion of OG toGlu. The Glu-Gln cycle is
signified by aVGln exchange flux, and the loss of Gln is expressed by theVeff flux, which is equal in value to theVPC flux throughmass-balance considera-
tions assuming constant metabolites pool sizes (metabolic steady-state). OAA ismodeled to exchange labeling with Asp through the transmitochondrial
fluxVx
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mass-balance and differential equations of the mathematical
model are provided in Supporting Information, which is
available online.
To evaluate the effect of small variations of the Glc C6
and Glx C2 FEs values on the metabolic rates, two data sets
with either a 10% artificially-increased FEGlc C6 (t56min) val-
ues or with a 10% decrease were generated and fitted to the
one-compartment model. The resulting metabolic rates were
compared with the original results by permutation analysis
followed by Student’s t-tests, as detailed previously.43
3 | RESULTS
3.1 | 1H-[13C] MRS coil tests on a [2-13C]
acetate phantom
To evaluate the modified RF coil design, both coils were
tested on the phantom containing 50% labeled [2-13C]acetate.
Using the original 13C-[1H] coil, the resulting inverted and
non-inverted spectra from the big voxel exhibited equally
high quality, and their corresponding SNRs were not differ-
ent from each other, i.e., 127.86 7.5 and 126.36 8.0
(P> 0.05), respectively (Figure 1A, bottom). SNRs of
inverted and non-inverted spectra from the hypothalamic
voxel under the identical settings were substantially reduced,
i.e., 30.56 2.2 and 30.46 2.3, respectively (Figure 1A, top).
Tests with the optimized 1H-[13C] coil yielded hypothalamic
inverted and non-inverted spectra with improved quality and
SNRs of 90.86 5.0 and 91.56 3.3, respectively.
3.2 | 1H-[13C] MRS of the mouse
hypothalamus at 14.1T
The metabolite linewidths of the non-edited spectra from the
mouse hypothalamus were 166 2Hz, and SNRs were 146
1, as measured with LCModel (Figure 3A). Neurochemical
quantification revealed high levels of GABA (3.836
0.08mmol/g) (mean6SEM between all animals), Ins
(7.386 0.16mmol/g), and total choline (GPC1PCho, 2.056
0.04mmol/g), and low levels of Ala (0.86 0.04mmol/g). In
addition, Glc (2.736 0.19mmol/g), Glu (8.986 0.30mmol/
g), Gln (3.516 0.14mmol/g), Lac (3.816 0.15mmol/g), and
Asp (2.266 0.08mmol/g) were quantified. Glc concentration
increased throughout the study, reaching a final level of
6.616 1.0mmol/g. The remaining metabolites had stable
concentrations, except Lac, which decreased to a final con-
centration of 2.826 0.6mmol/g.
In the edited spectra, 13C-coupled 1H resonances of Lac
C3, Ala C3, GABA C3, Glx C3, GABA C2, Glu C4, Gln
C4, Asp C3, GABA C4, Glx C2, and Glc C6 were clearly
visible in an 11-min scan, 150min after the beginning of the
infusion (Figure 3B).
FIGURE 3 A, Typical non-edited spectrum (80 scans, 5.3min with
the acquisition distributed in 11min) of the mouse hypothalamus after
150min of continuous Glc infusion. B, 13C-edited spectrum (160 scans,
11min) of the same animal and time point. C, LCModel-fit of the 13C-
edited spectrum and individual fit of Glc C6, Glu (C2, C3 and C4), Gln
(C2, C3 and C4), Lac C3, Ala C3, Asp C3, and GABA (C2, C3, and C4).
The vertical scale of the edited spectrum (line broadening5 5Hz) is 3
times lower than the scale in the non-edited spectrum
LIZARBE ET AL.
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During the first 11min of acquisition, the presence of
Glc C6 and Lac C3 resonances in the 13C-edited spectra was
revealed (Figure 4). 13C-coupled 1H resonances of Glu C4
and Gln C4 appeared in the second time-point spectrum, and
GABA C2, Glx C3 became perceptible from the 3rd edited
spectrum.
SNRs of edited spectra increased along the time course.
For all the mice, at the first time point measurement, SNR
was approximately 2, as measured with LCModel, while in
the last time point it was around 4. Mean CRLBs of the 13C-
coupled resonances of all time points were 156 5% for Glc
C6, 66 5% for Glu C4, 176 10% for Gln C4, 76 1% for
Lac C3, 186 11% for GABA C2, 246 19% for GABA C3,
116 10% for Glx C3, and 186 7% for Glx C2. Concentra-
tions for Asp C3 were obtained from the 18min time resolu-
tion spectra, and the average CRLB was 326 8%.
Quantification of Ala C3 was only possible from approi-
mately 150min of glucose infusion and not in all animals.
Correlation of spectral intensities derived from LCModel fit-
ting (Figure 3C) generally resulted in a very small value
except for Glu C3 with Gln C3, Glu C2 with Gln C2, and
between Glx C2 and Glc C6, where absolute correlation val-
ues were around -0.8 for almost all time points. These high
correlations precluded the use of Glu C3 and Gln C3 and
Glu C2 and Gln C2 independently. Therefore, Glx C2 and
C3 were used instead.
FEs curves were obtained for Lac C3, Glu C4, Gln C4,
GABA (C2, C3 and C4), Glx C3, Glx C2, and Asp C3
(Figure 5).
FIGURE 4 Stack of 1H-[13C] edited spectra (line broade-
ning5 5Hz) showing one time course (190min) accumulation of labeling
in a single animal
FIGURE 5 Mean (6SEM) turnover curves of the FE of lactate C3 (Lac C3), glutamate C4 (Glu C4), glutamine C4 (Gln C4), GABAC2, C3 and C4,
glutamate C31 glutamine C3 (Glx C3), glutamate C21 glutamine C2 (Glx C2), and aspartate C3 (Asp C3). Lines in Lac C3 FE curves depict the respec-
tive fitting of the data to the step function f ðtÞ5ða  t1bÞ  12expð2c  tÞ and lines in Glu C4, Gln C4, GABAC2, C3, and C4, Glx C3, Glx C2, and
Asp C3 show the fit of the data to the one-compartment metabolic model
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The fractional enrichment of Lac C3 rose rapidly, reach-
ing a plateau enrichment of 0.536 0.09. As for Glu C4 and
Gln C4, their 13C concentrations reached steady-state values
of 5.036 0.08mmol/g and 1.896 0.40mmol/g, respectively,
after approximately 130min of glucose infusion (FE of
0.556 0.03 and 0.506 0.06, respectively). GABA C2 values
reached a plateau of 1.636 0.47mmol/g at 150min
(FE5 0.496 0.06), GABA C3 reached a stable concentra-
tion of 1.606 0.09mmol/g toward the end of the measure-
ments and GABA C4 1.516 0.15mmol/g (FE of 0.476 0.11
and 0.456 0.10, respectively). Glx C3 and Glx C2 reached
steady-state values of 5.656 0.48mmol/g and 5.556
0.11mmol/g at approximately 150min (FE of 0.446 0.04
and 0.436 0.08, respectively). Asp C3 reached a steady-
state of 1.006 0.22mmol/g (FE5 0.496 0.10) after approxi-
mately 90min.
3.3 | Mathematical modeling of hypothalamic
metabolism
Fitting of the mathematical model of hypothalamic metabo-
lism to the FEs turnover curves yielded a TCA flux VTCA of
0.836 0.05lmol/g/min, a transmitochondrial flux Vx of
0.686 0.21lmol/g/min, a neurotransmitter Glu-Gln flux
VGln of 0.416 0.07lmol/g/min, a Glu-GABA flux VGABA
of 0.136 0.01lmol/g/min, a dilution flux Vdil of 0.066
0.01lmol/g/min and a VPC of 0.046 0.01lmol/g/min.
Using the calculated VTCA, VGABA, VPC, and Vdil fluxes, the
pyruvate dehydrogenase rate VPDH and total rate of mito-
chondrial oxidation (VPDH1Vdil) were determined, resulting
in a VPDH of 0.946 0.05lmol/g/min and VPDH1Vdil of
1.016 0.05lmol/g/min. Fluxes were used to generate FE
simulated values that are in excellent agreement with the
experimental data (Figure 5). Correlation values between
fluxes were generally <0.4 and the highest correlation was
between VGABA and VTCA (-0.4). Modeling of the artificially
augmented or decreased Glc C6 FEs yielded values of the
metabolic rates that were not significantly different
(P> 0.05) from the original results.
4 | DISCUSSION
The present study reports for the first time the feasibility to
obtain metabolic fluxes of the mouse hypothalamus noninva-
sively using dynamic indirect 1H-[13C] MRS at 14T. The
particular challenges of dynamic 13C MRS on the mouse
hypothalamus were overcome by two approaches: (1) using
proton detection methods with labeled [1,6-13C2]glucose and
(2) maximizing the sensitivity of 1H detection with an opti-
mized surface coil geometry. Additionally, a new one-
compartment model that encompasses the main metabolic
characteristics of the hypothalamus is proposed.
The optimized coil arrangement generated SNRs of the
hypothalamic spectra from the [2-13C]acetate phantom (90)
that were substantially enhanced, e.g., 3 times higher, as
compared to the SNR from the identical voxel settings using
the original 13C-[1H] coil configuration (30), and only 30%
less than the SNR from the large voxel with the nonopti-
mized geometry (130). Hence, the SNRs of the hypothala-
mic edited spectra in vivo over 11min were comparable to
that obtained from a 60mL volume with a 5-min time resolu-
tion during dynamic 13C MRS in the mouse cortex.6
The use of [1,6-13C2]glucose infusion in this study pro-
vided two unique advantages over the widely used [1-13C]
glucose and [U-13C]glucose substrates. First, it increased the
13C labeling by two-fold, compared with [1-13C]glucose.
Second, it required less RF power for the adiabatic pulses
than is needed for [U-13C]glucose. [1,6-13C2]Glucose-
derived signals require narrower inversion and decoupling
RF bandwidths, i.e., 40 ppm (from Lac C3 to Glc C6), com-
pared with 60 ppm for [U-13C]glucose signals (from Lac C3
to Glc C2-5). With narrower bandwidths, adiabatic pulses
require less RF power. Using [1,6-13C2]glucose, however,
we observed high correlations between the Glc C6 and Glx
C2 fitted signal intensities, due to their overlapping resonan-
ces (3.88-3.71 ppm, 3.76 ppm and 3.75 ppm for Glc, Gln,
and Glu, respectively) (Figure 3C). To correct for these cor-
relations, and based on the design of the glucose infusion
protocol,34 we used a constant FE for Glc C6, measured in
the first time point.
This assumption resulted in approximately equivalent
calculated steady-state FEs of Glx C2 and Glx C3, as noted
in previous studies.43 Moreover, small artificial variations of
the glucose enrichment (610%) did not significantly affect
the calculated metabolic flux values. Glx C2-Glc C6 correla-
tions could be avoided using [U-13C]glucose, but reliable
quantification of the Glc C2-C5 positions would require the
use of substantially higher RF power for the inversion and
decoupling. The geometrical configuration of our optimized
coil, with the proton loops closer to the brain surface, results
in a greater 13C loop-hypothalamus distance, compared with
the original configuration, and required the use of higher
inversion and decoupling RF power on the 13C channel. In
this sense, the correct quantification of the [U-13C]glucose-
derived Glc C2-C5 signals might have resulted in needing to
use RF power exceeding the coil limits. Moreover, with
[U-13C]glucose, the incorporation of Ala C2 resonance (at
3.78 ppm) would need to be taken into account.
The average FE turnover curves from the mouse hypothal-
amus were fitted to a modified one-compartment model of
brain metabolism that includes two of the main features of
hypothalamic metabolism, namely the abundant GABAergic
neurons and the potential contributions of energy sources other
than glucose.44 In our model, the total rate of mitochondrial
oxidation (1.016 0.05lmol/g/min) was very similar to the
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whole mouse brain TCA cycle rate (1.056 0.04lmol/g/min)
reported by Xin et al.6 and slightly higher than the value
reported by Lai et al.45 (0.766 0.04lmol/g/min). In the afore-
mentioned studies, however, no net contribution of nonlabeled
substrates was considered, while our results indicate a 6% con-
tribution of fatty acids or ketone bodies to the total mitochon-
drial oxidation rate.
Although it is small, this value refers explicitly to the
net uptake of nonlabeled sources at the level of acetyl-CoA, and,
if the fatty acid or ketone body contribution to hypothalamic
metabolism changed, as it does in pathological conditions,46–50
this change should become measurable. Within the total rate of
oxidation reported here, 82% can be attributed to the TCA rate,
13% to GABAergic recycling and approximately 4% to VPC.
This represents a higher hypothalamic GABAergic metabolism
than that reported in rats (9%)39 and a very similar VPC contribu-
tion than that previously reported in mice (5%).45 The VGABA
flux fitted in our study (0.136 0.01lmol/g/min) is very similar
to the GABAergic neurotransmitter cycling flux (0.116
0.01mmol/g/min) measured in the rat brain in vivo39 and esti-
mated in the mouse thalamic-hypothalamic area from brain
extracts,17 and it accounts for approximately 24% of the total
neurotransmitter flux, similar to the 22% and 23% contributions
described in the rat brain.39,51
The transmitochondrial (0.686 0.21lmol/g/min) and
Glu-Gln rates (0.416 0.07mmol/g/min) are slightly higher in
the hypothalamus than previously reported in rodents,6,7,29
which can be related to the fact that glutamate underlies the
majority of fast synaptic activity in this area.52 However,
when comparing these results to previous investigations
using two- or three-compartment models, it should be noted
that, because our model does not include separate cellular
compartments, the neurotransmitter fluxes described here are
simplifications of the more complex models, which take into
account neurotransmitter cycling between compartments.
The excellent agreement between the fit and the experi-
mental data reflects the suitability of the hypothalamic meta-
bolic model proposed here. Specifically, the good agreement
between the fitted GABA C2, C3, and C4 FE values with the
experimental concentrations suggests that the simplified
model can be used to determine the role of GABAergic neu-
rons in hypothalamic metabolism.
Despite the narrow linewidths achieved in this study, Glu
C3 resonances were strongly correlated with Gln C3, and
likewise Glu C2 with Gln C2, due to the spectral overlap
that persists even at 14.1T. This strong correlation limited
the number of amino acids labeling positions and, therefore,
precluded the extension of the modeling to a full two- or
three-compartment model of neurotransmitter metabo-
lism.39,53 Such models could potentially improve the deter-
mination of the Vdil flux, especially because it has been
suggested that fatty acids and ketone bodies are mostly taken
up by astrocytes.42,54,55
We conclude that in vivo 1H-[13C] MRS is feasible in the
mouse hypothalamus despite its very small size and distance
from the surface coil. The application of 13C MRS to such
small volumes opens the possibility of studying the mouse
brain metabolism in vivo in the hypothalamus and other
areas with specific physiological or pathological conditions.
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